RSV vaccine: Moderna seeks regulatory approval of RSV vaccine for people 60 and older

Moderna seeks regulatory approval of RSV vaccine for people 60 and older - UPI.com Moderna has submitted its RSV vaccine for people 60 and older regulatory approval in the United States, European Union, Switzerland and Australia. UPI

...

Moderna said the regulatory applications come after positive data from a study of approximately 37,000 adults 60 or older in 22 countries. Its vaccine to protect from respiratory syncytial virus was found in these trials to be 83.7% effective as defined by two or more symptoms.

...